 |
 |
 |
|
A Random Forest Classifier Based on a 30-Gene Signature Distinguishes Patients With Bridging Fibrosis From Those With Cirrhosis Due to NASH
|
|
|
AASLD 2020 Nov 11-16 virtual
Yevgeniy Gindin,1Jay Chuang,1Andrew Billin,1Marianne Camargo,1Ryan S. Huss,1Chuhan Chung,1Robert P. Myers,1Zobair Younossi,2Stephen A. Harrison,3Quentin M. Anstee,4Arun J. Sanyal,5Rohit Loomba6
1Gilead Sciences, Inc., Foster City, CA; 2Inova Fairfax Hospital, Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA; 3Pinnacle Clinical Research, San Antonio, TX; 4Institute of Cellular Medicine, Newcastle University Faculty of Medical Sciences, Newcastle upon Tyne, UK;5Virginia Commonwealth University, Richmond, VA; 6UC San Diego NAFLD Research Center, La Jolla, CA





|
|
|
 |
 |
|
|